Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
605 | 13295 | 33.2 | 72% |
Classes in level above (level 3) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
398 | 27726 | MULTIPLE MYELOMA//AMYLOIDOSIS//THALIDOMIDE |
Classes in level below (level 1) |
ID, lev. below | Publications | Label for level below |
---|---|---|
693 | 3091 | MULTIPLE MYELOMA//LENALIDOMIDE//BORTEZOMIB |
2367 | 2198 | PLASMA CELL LEUKEMIA//PRIMARY PLASMA CELL LEUKEMIA//MMSET |
5882 | 1493 | THALIDOMIDE//CC 5013//CC 4047 |
6328 | 1433 | PLASMACYTOMA//EXTRAMEDULLARY PLASMACYTOMA//SOLITARY PLASMACYTOMA |
6796 | 1366 | IMMUNOFIXATION ELECTROPHORESIS//FREE LIGHT CHAINS//SERUM FREE LIGHT CHAINS |
8013 | 1227 | LIGHT CHAIN DEPOSITION DISEASE//CRYSTAL STORING HISTIOCYTOSIS//HEAVY CHAIN DEPOSITION DISEASE |
8161 | 1213 | MYELOMA BONE DISEASE//CAM DR//HEIM |
12099 | 868 | WALDENSTROMS MACROGLOBULINEMIA//WALDENSTROM MACROGLOBULINEMIA//BING WALDENSTROMS MACROGLOBULINEMIA |
23918 | 276 | MOTT CELL//RUSSELL BODIES//MOTT CELLS |
30929 | 130 | MU HEAVY CHAIN DISEASE//HEAVY CHAIN DISEASE//GAMMA HEAVY CHAIN DISEASE |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | MULTIPLE MYELOMA | Author keyword | 2091 | 48% | 24% | 3212 |
2 | THALIDOMIDE | Author keyword | 847 | 58% | 7% | 966 |
3 | MYELOMA | Author keyword | 437 | 44% | 6% | 765 |
4 | LENALIDOMIDE | Author keyword | 311 | 54% | 3% | 404 |
5 | PLASMACYTOMA | Author keyword | 247 | 56% | 2% | 297 |
6 | BORTEZOMIB | Author keyword | 206 | 34% | 4% | 503 |
7 | EXTRAMEDULLARY PLASMACYTOMA | Author keyword | 203 | 82% | 1% | 117 |
8 | LIGHT CHAIN DEPOSITION DISEASE | Author keyword | 185 | 91% | 1% | 78 |
9 | PLASMA CELL LEUKEMIA | Author keyword | 167 | 84% | 1% | 92 |
10 | MYELOMA THER Y | Address | 144 | 54% | 1% | 188 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | MULTIPLE MYELOMA | 2091 | 48% | 24% | 3212 | Search MULTIPLE+MYELOMA | Search MULTIPLE+MYELOMA |
2 | THALIDOMIDE | 847 | 58% | 7% | 966 | Search THALIDOMIDE | Search THALIDOMIDE |
3 | MYELOMA | 437 | 44% | 6% | 765 | Search MYELOMA | Search MYELOMA |
4 | LENALIDOMIDE | 311 | 54% | 3% | 404 | Search LENALIDOMIDE | Search LENALIDOMIDE |
5 | PLASMACYTOMA | 247 | 56% | 2% | 297 | Search PLASMACYTOMA | Search PLASMACYTOMA |
6 | BORTEZOMIB | 206 | 34% | 4% | 503 | Search BORTEZOMIB | Search BORTEZOMIB |
7 | EXTRAMEDULLARY PLASMACYTOMA | 203 | 82% | 1% | 117 | Search EXTRAMEDULLARY+PLASMACYTOMA | Search EXTRAMEDULLARY+PLASMACYTOMA |
8 | LIGHT CHAIN DEPOSITION DISEASE | 185 | 91% | 1% | 78 | Search LIGHT+CHAIN+DEPOSITION+DISEASE | Search LIGHT+CHAIN+DEPOSITION+DISEASE |
9 | PLASMA CELL LEUKEMIA | 167 | 84% | 1% | 92 | Search PLASMA+CELL+LEUKEMIA | Search PLASMA+CELL+LEUKEMIA |
10 | WALDENSTROMS MACROGLOBULINEMIA | 133 | 60% | 1% | 145 | Search WALDENSTROMS+MACROGLOBULINEMIA | Search WALDENSTROMS+MACROGLOBULINEMIA |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | NEWLY DIAGNOSED MYELOMA | 483 | 87% | 2% | 240 |
2 | LENALIDOMIDE PLUS DEXAMETHASONE | 460 | 80% | 2% | 284 |
3 | MULTIPLE MYELOMA | 416 | 18% | 16% | 2099 |
4 | MONOCLONAL GAMMOPATHY | 357 | 45% | 5% | 604 |
5 | THALIDOMIDE PLUS DEXAMETHASONE | 297 | 87% | 1% | 144 |
6 | THALIDOMIDE | 284 | 34% | 5% | 691 |
7 | CONSENSUS PANEL RECOMMENDATIONS | 256 | 92% | 1% | 102 |
8 | PLASMA CELL LEUKEMIA | 220 | 84% | 1% | 122 |
9 | BORTEZOMIB | 217 | 35% | 4% | 509 |
10 | UNDETERMINED SIGNIFICANCE | 217 | 32% | 4% | 567 |
Journals |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 36 | 24% | 1% | 132 |
2 | CLINICAL LYMPHOMA & MYELOMA | 32 | 29% | 1% | 93 |
3 | CLINICAL LYMPHOMA | 5 | 18% | 0% | 25 |
4 | BLOOD CANCER JOURNAL | 5 | 14% | 0% | 32 |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
MEDICAL PROGRESS Multiple Myeloma | 2011 | 407 | 80 | 91% |
Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma | 2009 | 323 | 26 | 96% |
Current treatment landscape for relapsed and/or refractory multiple myeloma | 2015 | 4 | 82 | 90% |
Drug therapy: Multiple myeloma | 2004 | 729 | 84 | 82% |
International Myeloma Working Group molecular classification of multiple myeloma: spotlight review | 2009 | 275 | 80 | 95% |
Multiple myeloma | 2009 | 258 | 113 | 94% |
Genetics of multiple myeloma: another heterogeneity level? | 2015 | 3 | 60 | 92% |
IMWG consensus on risk stratification in multiple myeloma | 2014 | 28 | 64 | 94% |
Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management | 2010 | 170 | 21 | 100% |
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders | 2009 | 237 | 34 | 82% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MYELOMA THER Y | 144 | 54% | 1.4% | 188 |
2 | JEROME LIPPER MULTIPLE MYELOMA | 102 | 54% | 1.0% | 133 |
3 | MYELOMA UNIT | 87 | 72% | 0.5% | 68 |
4 | BING WALDENSTROMS MACROGLOBULINEMIA | 63 | 77% | 0.3% | 43 |
5 | AZIENDA OSPED S GIOVANNI BATTISTA | 35 | 64% | 0.3% | 35 |
6 | DONNA D DONALD M LAMBERT MYELOMA GENET | 33 | 77% | 0.2% | 23 |
7 | SERAGNOLI HEMATOL | 32 | 78% | 0.2% | 21 |
8 | MULTIPLE MYELOMA SECT | 30 | 68% | 0.2% | 27 |
9 | IST EMATOL SERAGNOLI | 27 | 71% | 0.2% | 22 |
10 | CLIN THER EUT | 26 | 15% | 1.2% | 158 |
Related classes at same level (level 2) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000012436 | AMYLOIDOSIS//TRANSTHYRETIN//AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS |
2 | 0.0000007610 | CHRONIC LYMPHOCYTIC LEUKEMIA//HAIRY CELL LEUKEMIA//CLL |
3 | 0.0000006762 | THROMBOPOIETIN//ONCOSTATIN M//LEUKEMIA INHIBITORY FACTOR |
4 | 0.0000006450 | CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY//VINFLUNINE//VINCRISTINE |
5 | 0.0000006025 | BISPHOSPHONATES//ZOLEDRONIC ACID//BISPHOSPHONATE |
6 | 0.0000005987 | PROTEASOME//UBIQUITIN//NEDD8 |
7 | 0.0000004791 | GUILLAIN BARRE SYNDROME//CASTLEMANS DISEASE//POEMS SYNDROME |
8 | 0.0000004572 | MANTLE CELL LYMPHOMA//MYCOSIS FUNGOIDES//DIFFUSE LARGE B CELL LYMPHOMA |
9 | 0.0000003985 | ESSENTIAL THROMBOCYTHEMIA//POLYCYTHEMIA VERA//MYELOFIBROSIS |
10 | 0.0000003893 | FIBRILLARY GLOMERULONEPHRITIS//NAIL PATELLA SYNDROME//YELLOW NAIL SYNDROME |